First-line treatment: Offer an angiotensin-converting enzyme inhibitor and a beta-blocker licensed for heart failure to people who have heart failure with reduced ejection fraction. Use clinical judgment when deciding which drug to start first. The gene discussed is ACE; the disease is heart failure.